Cargando…

COVID-19 Adaptive Humoral Immunity Models: Weakly Neutralizing Versus Antibody-Disease Enhancement Scenarios

The interplay between the virus, infected cells and immune responses to SARS-CoV-2 is still under debate. By extending the basic model of viral dynamics, we propose here a formal approach to describe neutralisation versus weak (or non-)neutralisation scenarios and compare them with the possible effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Danchin, Antoine, Pagani-Azizi, Oriane, Turinici, Gabriel, Yahiaoui, Ghozlane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375081/
https://www.ncbi.nlm.nih.gov/pubmed/35962852
http://dx.doi.org/10.1007/s10441-022-09447-1
_version_ 1784767883735203840
author Danchin, Antoine
Pagani-Azizi, Oriane
Turinici, Gabriel
Yahiaoui, Ghozlane
author_facet Danchin, Antoine
Pagani-Azizi, Oriane
Turinici, Gabriel
Yahiaoui, Ghozlane
author_sort Danchin, Antoine
collection PubMed
description The interplay between the virus, infected cells and immune responses to SARS-CoV-2 is still under debate. By extending the basic model of viral dynamics, we propose here a formal approach to describe neutralisation versus weak (or non-)neutralisation scenarios and compare them with the possible effects of antibody-dependent enhancement (ADE). The theoretical model is consistent with the data available in the literature; we show that both weakly neutralising antibodies and ADE can result in final viral clearance or disease progression, but that the immunodynamics are different in each case. As a significant proportion of the world’s population is already naturally immune or vaccinated, we also discuss the implications for secondary infections after vaccination or in the presence of immune system dysfunctions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10441-022-09447-1.
format Online
Article
Text
id pubmed-9375081
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-93750812022-08-15 COVID-19 Adaptive Humoral Immunity Models: Weakly Neutralizing Versus Antibody-Disease Enhancement Scenarios Danchin, Antoine Pagani-Azizi, Oriane Turinici, Gabriel Yahiaoui, Ghozlane Acta Biotheor Regular Article The interplay between the virus, infected cells and immune responses to SARS-CoV-2 is still under debate. By extending the basic model of viral dynamics, we propose here a formal approach to describe neutralisation versus weak (or non-)neutralisation scenarios and compare them with the possible effects of antibody-dependent enhancement (ADE). The theoretical model is consistent with the data available in the literature; we show that both weakly neutralising antibodies and ADE can result in final viral clearance or disease progression, but that the immunodynamics are different in each case. As a significant proportion of the world’s population is already naturally immune or vaccinated, we also discuss the implications for secondary infections after vaccination or in the presence of immune system dysfunctions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10441-022-09447-1. Springer Netherlands 2022-08-13 2022 /pmc/articles/PMC9375081/ /pubmed/35962852 http://dx.doi.org/10.1007/s10441-022-09447-1 Text en © Prof. Dr. Jan van der Hoeven stichting voor theoretische biologie 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Regular Article
Danchin, Antoine
Pagani-Azizi, Oriane
Turinici, Gabriel
Yahiaoui, Ghozlane
COVID-19 Adaptive Humoral Immunity Models: Weakly Neutralizing Versus Antibody-Disease Enhancement Scenarios
title COVID-19 Adaptive Humoral Immunity Models: Weakly Neutralizing Versus Antibody-Disease Enhancement Scenarios
title_full COVID-19 Adaptive Humoral Immunity Models: Weakly Neutralizing Versus Antibody-Disease Enhancement Scenarios
title_fullStr COVID-19 Adaptive Humoral Immunity Models: Weakly Neutralizing Versus Antibody-Disease Enhancement Scenarios
title_full_unstemmed COVID-19 Adaptive Humoral Immunity Models: Weakly Neutralizing Versus Antibody-Disease Enhancement Scenarios
title_short COVID-19 Adaptive Humoral Immunity Models: Weakly Neutralizing Versus Antibody-Disease Enhancement Scenarios
title_sort covid-19 adaptive humoral immunity models: weakly neutralizing versus antibody-disease enhancement scenarios
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375081/
https://www.ncbi.nlm.nih.gov/pubmed/35962852
http://dx.doi.org/10.1007/s10441-022-09447-1
work_keys_str_mv AT danchinantoine covid19adaptivehumoralimmunitymodelsweaklyneutralizingversusantibodydiseaseenhancementscenarios
AT paganiazizioriane covid19adaptivehumoralimmunitymodelsweaklyneutralizingversusantibodydiseaseenhancementscenarios
AT turinicigabriel covid19adaptivehumoralimmunitymodelsweaklyneutralizingversusantibodydiseaseenhancementscenarios
AT yahiaouighozlane covid19adaptivehumoralimmunitymodelsweaklyneutralizingversusantibodydiseaseenhancementscenarios